Luckin Coffee Inc., a Chinese coffee company and coffeehouse chain, reported its annual sales and revealed that the numbers have surpassed Starbucks’ sales in China. It beat its rival in the Chinese market last year, a big achievement after being delisted from the Nasdaq four years ago.
According to CNN Business, Luckin Coffee did not present a breakdown of its revenue according to geography, but most of its sales were from China. The company has stores in Singapore, and 30 branches operate there.
Coffee Chains’s Boosted Revenue
The profits of Luckin Coffee reportedly increased by 87% to CNY24.9 billion or about $3.5 billion in the year ended Dec. 31. The surge was credited to the company’s faster action in expanding its stores and launching new products.
In comparison, the revenue of Starbucks China was only $3 billion in the year ended Sept. 30, 2023. Luckin Coffee’s financial results were released on Friday, Feb. 23.
It was also indicated that the coffee chain could surpass Starbucks regarding the number of outlets in mainland China. Due to its rapid expansion, Luckin Coffee has 16,218 branches in the country, almost double its count in 2022, which was only around 8,200. On the other hand, Starbucks has 6,975 stores as of the end of January 2024.
“We remain focused on our pricing and expansion strategy to sustain our growth and market share,” Luckin Coffee’s chairman and chief executive officer, Jinyi Guo, commented about their growth.
Taking Over China
Meanwhile, China Daily reported that Luckin Coffee has become the largest coffee chain in the country today, and it’s all thanks to the changing habits of coffee consumers. Moreover, the company transformed its stores into something people feel comfortable visiting as they adapt to the new changes more than Starbucks.


Apple Turns 50: From Garage Startup to AI Crossroads
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover
Britain Courts Anthropic Amid US Defense Department Dispute
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown 



